autologous anti-BCMA CAR T cells UF-KURE-BCMA
A preparation of autologous CD4+ and CD8+ T lymphocytes that have been transduced with a lentiviral vector (LV) encoding for a chimeric antigen receptor (CAR) specific for human B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily member 17; TNFRSF17), with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-BCMA CAR T cells UF-KURE-BCMA specifically recognize and induce selective toxicity in BCMA-expressing tumor cells. BCMA, a tumor specific antigen and a receptor for both a proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF), is a member of the tumor necrosis factor (TNF) receptor superfamily (TNFRSF) and plays a key role in plasma cell survival. BCMA is found on the surfaces of plasma cells and overexpressed on malignant plasma cells.
Synonym: | autologous anti-BCMA CAR-expressing CD4+/CD8+ T lymphocytes UF-KURE-BCMA |
---|---|
Code name: | UF-KURE-BCMA |